News
During the AMA, one user asked: “Are you still negotiating with CVS over Zepbound coverage? Is it possible that it will be offered again in the future under Caremark plans?” Lilly’s Pacheco ...
Health insurance plans are changing how they cover GLP-1 drugs for weight loss to rein in costs, forcing doctors and patients ...
3d
Zacks.com on MSNLLY vs. ABBV: Which Pharma Powerhouse is the Better Bet?Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...
7d
Zacks.com on MSNNovo Nordisk Stock Rises 6% in a Week: What Should Investors Do?NVO jumps nearly 6% in a week on amycretin pipeline boost and hedge fund interest, but competition looms large.
Earlier this month, CVS Caremark announced that it will now cover Wegovy under its pharmacy benefit plans — but it will no longer cover Zepbound. A study published in the New England Journal of ...
A survey by PSG has found that the pressure to control drug costs is leading some payers to look into unbundling pharmacy ...
Hims also sells liraglutide, a generic version of an older Novo diabetes drug that also causes weight loss, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results